Biolight International AB: Quarterly Report January - March 31, 2003
05 mai 2003 10h59 HE
|
Biolight
STOCKHOLM, Sweden, May 05, 2003 (PRIMEZONE) -- Biolight International AB (publ) (Other OTC:BLGIF):
Sales during the first quarter amounted to SEK 457 T (513).
The clinical acceptance within the...
Biolight: Semi-Annual Report January 1 - June 30, 2002
29 août 2002 06h02 HE
|
Biolight
STOCKHOLM, Sweden, Aug. 29, 2002 (PRIMEZONE) -- Biolight International AB (publ): Second quarter 2002
-- Sales during the first six months amounted to SEK 1,212 T (325).
Sales during the...
Biolight: First Commercial Order from National Health
24 juin 2002 05h12 HE
|
Biolight
STOCKHOLM, Sweden, June 24, 2002 (PRIMEZONE) -- Biolight has signed its first agreement with the home medical care service in western Goteborg, Sweden, regarding treatment of patients with chronic...
The Board of Directors of Biolight International AB Presents Annual Earnings Figures for the Financial Year 2001 (with link)
22 févr. 2002 03h25 HE
|
Biolight
STOCKHOLM, Sweden, Feb. 22, 2002 (PRIMEZONE) -- Biolight International AB:
Important events during the year:
-- A phase III study on decubitus ulcers has been finalised during
the year....
Biolight International AB Prepares Distribution in the Far East
30 janv. 2002 05h35 HE
|
Biolight
STOCKHOLM, Sweden, January 30, 2002 (PRIMEZONE) -- The company has reached a distribution agreement regarding Dental Care with C&N Med-Dent CO., Ltd in Taiwan. The company has also signed a...
FDA Approval - 510 k - for Biolight
24 janv. 2002 04h50 HE
|
Biolight
STOCKHOLM, Sweden, Jan. 24, 2002 (PRIMEZONE) -- Biolight:
The company has gained FDA approval - 510(k) - for Physiotherapeutic Care. This approval allows the company to market and sell its...